GLP3 RT

Categories:

GLP3 RT is an experimental triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon pathways for research-use-only applications. Designed to mimic multi-agonist compounds such as retatrutide, it is utilized in laboratory investigations exploring metabolic regulation, glucose control, and lipid metabolism. For research use only.

Price range: $200.00 through $400.00

Guaranteed Safe Checkout

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

GLP3 RT

GLP3 RT is an experimental triple-hormone receptor agonist designed for research-use-only applications. It is engineered to target the GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors, mimicking the pharmacological profile observed in investigational multi-agonist compounds such as retatrutide. This multi-receptor approach is studied for its potential synergistic effects on metabolic regulation.

Research Context

Triple-agonist peptides represent a next-generation research focus in metabolic science. By simultaneously activating GIP, GLP-1, and glucagon pathways, GLP3 RT is utilized in preclinical and laboratory settings to explore mechanisms related to energy expenditure, appetite regulation, glucose homeostasis, and lipid metabolism. Experimental multi-agonists in this category have demonstrated superior weight reduction outcomes in controlled studies, with reported reductions of up to 24.2%–28.7%, alongside marked improvements in glycemic parameters and liver fat reduction.

Research Overview

In laboratory investigations, triple-hormone receptor agonists are studied for their ability to modulate insulin secretion, enhance satiety signaling, increase energy expenditure, and influence hepatic lipid metabolism. GLP3 RT is intended exclusively for controlled in vitro and in vivo experimental models to evaluate receptor binding activity, metabolic pathway signaling, and pharmacodynamic properties.

Key Research Focus Areas

  • Multi-receptor activation (GIP, GLP-1, glucagon) and downstream signaling pathways
  • Experimental models of glucose metabolism and insulin dynamics
  • Energy balance, thermogenesis, and appetite regulation research
  • Hepatic lipid metabolism and liver fat reduction studies
  • Comparative analysis of triple-agonist peptide analogs

Safety and Compliance Considerations

GLP3 RT is strictly designated for research use only and is not approved for human or animal consumption. All handling, storage, and experimental procedures must comply with institutional laboratory standards and applicable regulatory guidelines. Proper safety and containment protocols are required.

For research use only. Not for human or animal consumption.

Size

60MG, 30MG

Reviews

There are no reviews yet.

Be the first to review “GLP3 RT”

Your email address will not be published. Required fields are marked *

Age Verification!

*By continuing, you confirm eligibility and legal compliance.